New oral formulation for 5-HT4 agonists or antagonists

Details for Australian Patent Application No. 2009200403 (hide)

Owner Novartis AG

Inventors Pfannkuche, Hans-Jurgen; Thewissen, Michael; Zuger, Othmar; Engel, Gunter; De Bruijn, Karel; Vitzling, Christian

Agent Davies Collison Cave

Pub. Number AU-A-2009200403

Parent 2006200048

Filing date 4 February 2009

Wipo publication date 26 February 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

19 February 2009 Complete Application Filed

26 February 2009 Application Open to Public Inspection

  Published as AU-A-2009200403

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200404-System and method for return electrode monitoring

2009200402-Appareil electrique de coupure a connexion haute et basse